RH

Richard Heyman

Vice Chairman of The Board of Trustees at Salk Institute for Biological Studies

Encinitas, California

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $50,000.00

  • Max Investment:

    $150,000,000.00

  • Target Investment:

    $25,000,000.00

Skills

Drug Discovery
Biotechnology
Lifesciences
Molecular Biology
Biochemistry
Pharmacology
Clinical Development
Drug Development
Cell Culture
Oncology
Pharmaceutical Industry
Cell Biology
In Vitro
Assay Development
In Vivo

Education

Lists including Richard

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

R
RayzeBio

2022

  • Chairperson of the Board

    2022

C
Curebound

2021

  • Board of Director and Scientific Advisory Board Member

    2021

ET
Enliven Therapeutics

2020

  • BOD Member/Chairman

    2020

    Drug Discovery and Development Biotech

LS
Life Science Cares San Diego

2020

  • Board of Managers

    2020

PP
PMV Pharmaceuticals, Inc.

2020

  • Chairman of the Board

    2020

AV
ARCH Venture Partners

2020

  • Venture Partner

    2020

VT
Vividion Therapeutics, Inc.

2018

  • Chairman/BOD member

    2018

SI
Salk Institute for Biological Studies

2015

  • Vice Chairman of The Board of Trustees

    2015

ORIC Pharmaceuticals

2014

  • Chairman of the BOD

    2014

Metacrine Inc.

2015 - 2022

  • Executive Chairman

    2015 - 2022